Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XLVI.c

Pulmonary veno-occlusive disease

Publications

Rose AG

Pulmonary veno-occlusive disease after chemotherapy with bleomycin.

Human pathology 1984 Feb;15;199 — 1984 Feb — 199

Rose AG

Pulmonary veno-occlusive disease due to bleomycin therapy for lymphoma. Case reports.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 1983 Oct 08;64;636-8 — 1983 Oct 08 — 636-8

Knight BK, Rose AG

Pulmonary veno-occlusive disease after chemotherapy.

Thorax 1985 Nov;40;874-5 — 1985 Nov — 874-5